| Charles Steenbergen Jr, MD | |
|
600 N Wolfe St, Baltimore, MD 21287-0005 | |
| (410) 955-5000 | |
| Not Available |
| Full Name | Charles Steenbergen Jr |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 46 Years |
| Location | 600 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649208364 | NPI | - | NPPES |
| 010232600 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | D64701 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced that its GQ-Dx genomic decision support system for the production of clinical-grade diagnostic reports from next-generation sequencing (NGS) runs now meets Health Insurance Portability and Accountability Act (HIPAA) security and privacy standards.
After thyroid cancer surgery, many patients should be in the position of deciding with their doctors whether to pursue treatment with radioactive iodine to help ease long-term follow-up and offer reassurance that the cancer is gone.
The Wall Street Journal: "As the U.S. debates the proper roles for the public and private sectors in health care, Italy's Lombardy region suggests a way that encouraging competition between the two can improve health care overall. For the past 10 years, public and private hospitals in Lombardy have competed directly for patients, and in doing so have created what is considered by many to be one of Europe's most efficient health-care systems" (Stancati, 4/13).
Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way - by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.
› Verified 8 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced that its GQ-Dx genomic decision support system for the production of clinical-grade diagnostic reports from next-generation sequencing (NGS) runs now meets Health Insurance Portability and Accountability Act (HIPAA) security and privacy standards.
After thyroid cancer surgery, many patients should be in the position of deciding with their doctors whether to pursue treatment with radioactive iodine to help ease long-term follow-up and offer reassurance that the cancer is gone.
The Wall Street Journal: "As the U.S. debates the proper roles for the public and private sectors in health care, Italy's Lombardy region suggests a way that encouraging competition between the two can improve health care overall. For the past 10 years, public and private hospitals in Lombardy have competed directly for patients, and in doing so have created what is considered by many to be one of Europe's most efficient health-care systems" (Stancati, 4/13).
Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way - by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Steenbergen Jr, MD Po Box 64478, Baltimore, MD 21264-4478 Ph: (410) 502-5982 | Charles Steenbergen Jr, MD 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-5000 |
News Archive
GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced that its GQ-Dx genomic decision support system for the production of clinical-grade diagnostic reports from next-generation sequencing (NGS) runs now meets Health Insurance Portability and Accountability Act (HIPAA) security and privacy standards.
After thyroid cancer surgery, many patients should be in the position of deciding with their doctors whether to pursue treatment with radioactive iodine to help ease long-term follow-up and offer reassurance that the cancer is gone.
The Wall Street Journal: "As the U.S. debates the proper roles for the public and private sectors in health care, Italy's Lombardy region suggests a way that encouraging competition between the two can improve health care overall. For the past 10 years, public and private hospitals in Lombardy have competed directly for patients, and in doing so have created what is considered by many to be one of Europe's most efficient health-care systems" (Stancati, 4/13).
Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way - by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.
› Verified 8 days ago
Serena Maria Bagnasco, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-955-2660 | |
Dr. Adeboye Oluwaseyi Osunkoya, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway, Johns Hopkins Pathology , Weinberg Room 2242, Baltimore, MD 21231 Phone: 405-808-5361 | |
Michael T. O'malley, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-644-4379 Fax: 410-644-4325 | |
Michael Edward Kallen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway St, Baltimore, MD 21287 Phone: 410-955-3580 Fax: 410-614-1287 | |
Deyin Xing, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 North Broadway, Weinberg 2268, Baltimore, MD 21231 Phone: 410-955-3580 Fax: 410-614-1287 | |
Matthew Grant Gabrielson, Pathology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-3980 | |
Robert A. Palermo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Baltimore, MD 21204 Phone: 443-849-2257 Fax: 443-849-3016 |